A Potential Prognostic Long Noncoding RNA Signature to Predict Recurrence among ER-positive Breast Cancer Patients Treated with Tamoxifen
Author:
Publisher
Springer Science and Business Media LLC
Subject
Multidisciplinary
Link
http://www.nature.com/articles/s41598-018-21581-w.pdf
Reference79 articles.
1. Torre, L. A. et al. Global cancer statistics, 2012. CA: a cancer journal for clinicians 65, 87–108, https://doi.org/10.3322/caac.21262 (2015).
2. Siegel, R. L., Miller, K. D. & Jemal, A. Cancer Statistics, 2017. CA: a cancer journal for clinicians 67, 7–30, https://doi.org/10.3322/caac.21387 (2017).
3. Rossi, L. & Pagani, O. Adjuvant Endocrine Therapy in Breast Cancer: Evolving Paradigms in Premenopausal Women. Curr Treat Options Oncol 18, 1534–6277 (2017).
4. Zwart, W., Terra, H., Linn, S. C. & Schagen, S. B. Cognitive effects of endocrine therapy for breast cancer: keep calm and carry on? Nat Rev Clin Oncol 12, 597–606, https://doi.org/10.1038/nrclinonc.2015.124 (2015).
5. Tao, Z. et al. Breast Cancer: Epidemiology and Etiology. Cell biochemistry and biophysics. https://doi.org/10.1007/s12013-014-0459-6 (2014).
Cited by 31 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. KIF20A is a Prognostic Marker for Female Patients with Estrogen Receptor-Positive Breast Cancer and Receiving Tamoxifen as Adjuvant Endocrine Therapy;International Journal of General Medicine;2023-08
2. FOXA1‐induced LINC00621 promotes lung adenocarcinoma progression via activating the TGF‐β signaling pathway;Thoracic Cancer;2023-06-05
3. Long Non-Coding RNAs, Cell Cycle, and Human Breast Cancer;Human Gene Therapy;2023-06-01
4. The Clinical Utility of lncRNAs and Their Application as Molecular Biomarkers in Breast Cancer;International Journal of Molecular Sciences;2023-04-18
5. Coding roles of long non-coding RNAs in breast cancer: Emerging molecular diagnostic biomarkers and potential therapeutic targets with special reference to chemotherapy resistance;Frontiers in Genetics;2023-01-06
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3